# FDA 483 - Evaric Pharmaceuticals Inc. - May 16, 2025

Source: https://www.keypedia.com/records/483/evaric-pharmaceuticals-inc/28b43d71-7b81-4187-8f7f-9182f64170bc

> FDA 483 for Evaric Pharmaceuticals Inc. on May 16, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Evaric Pharmaceuticals Inc.
- Inspection Date: 2025-05-16
- Product Type: drugs
- Office Name: New York District Office
- Summary: Evaric Pharmaceuticals Inc. in Hauppauge, NY, received a Form 483 with four observations during an FDA inspection. The firm was cited for significant deficiencies in equipment cleaning validation and practices, as well as inadequate process validation. Additionally, issues were noted regarding material segregation and a lack of systems to ensure compliance with the Drug Supply Chain Security Act.

## Related Documents

- [483 - 2026-05-24](https://www.keypedia.com/records/483/evaric-pharmaceuticals-inc/5ab8706f-a525-42ea-bd9d-126d9ab69f62)
- [483 - 2021-03-01](https://www.keypedia.com/records/483/evaric-pharmaceuticals-inc/d0eacb43-309d-43c7-9db0-271c05fec4cf)

## Related Officers

- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)
- [Luxuly Abraham](https://www.keypedia.com/people/luxuly-abraham/d33e3164-ec89-488b-bab9-a9ec30544970)

Company: https://www.keypedia.com/companies/evaric-pharmaceuticals-inc/0f29a015-1b48-40b9-a0a7-04ec9c3e15b4

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d